Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology (EM Waves, Transdermal, Optical, Enzymatic), Modality (Wearable, Non-wearable/Benchtop, Embedded Devices) By End User (Hospitals, Clinics, Homecare setting), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
The global Non-Invasive Blood Glucose Monitoring Devices Market was valued at US$ 24.22 Mn in 2023 and is expected to reach US$ 77.63 Mn by 2031, growing at a compound annual growth rate (CAGR) of 15.59% from 2024 to 3031, as highlighted in a new report published by Coherent Market Insights.
Non-invasive blood glucose monitoring devices help monitor blood glucose levels without drawing blood. These devices provide painless monitoring and help manage diabetes more effectively. These devices utilize technologies such as infrared, spectroscopic, thermometric etc. to extract glucose information through human tissue such as skin, tears etc.
Global Non-Invasive Blood Glucose Monitoring Devices Market- Drivers
Growing diabetic population globally is the primary factor driving the market growth. According to International Diabetes Federation, around 463 million adults aged between 20-79 years were living with diabetes in 2019 worldwide and it is projected to rise to 700 million by 2045. Increasing demand for painless monitoring solutions among diabetic patients is another key aspect augmenting the market expansion. Non-invasive devices eliminate pain associated with regular finger pricks and make monitoring more convenient. Furthermore, technological advancements in non-invasive monitoring techniques have improved accuracy of these devices, thereby boosting their adoption rate.
Global Non-Invasive Blood Glucose Monitoring Devices Market - Restraints
One of the major restraints faced by the non-invasive blood glucose monitoring devices market is the technological limitations surrounding current non-invasive methods. Existing non-invasive options have not achieved the same level of accuracy as invasive methods involving fingerstick blood samples. Variations in results can occur due to factors affecting signal transmission through the skin. This undermines user confidence and trust in these devices. Some techniques are also constrained in terms of depth of signal penetration and may not work reliably on all body types or skin conditions. The limitations in precision and reliability have hindered faster adoption of non-invasive methods in clinical use. Intensive research is ongoing to overcome these challenges through novel technological approaches.
Global Non-Invasive Blood Glucose Monitoring Devices Market- Opportunities
Another major factor fueling the non-invasive blood glucose monitoring devices market is the improved patient compliance and convenience offered compared to existing invasive methods. Finger pricking can deter diabetics from regularly checking glucose levels due to pain and discomfort. This reduces medication adherence and management of the condition. Non-invasive techniques eliminate the need for needles and blood samples. They offer painless monitoring that is hassle-free and discreet. This significantly boosts patient compliance with glucose testing routines. The non-invasive nature improves convenience and allows for flexible testing anytime, anywhere without preparation. The enhanced ease of use and compliance is a key driver attracting more consumers to these technologies.
Global Non-Invasive Blood Glucose Monitoring Devices Market Segmentation:
The global Non-Invasive Blood Glucose Monitoring Devices Market report is segmented into technology, modality, end user, and region
Based on the technology, the market is segmented into EM waves , transdermal, optical, enzymatic. Out of which, the EM waves segment is expected to hold a dominant position in the global non-invasive blood glucose monitoring devices market during the forecast period, and this is attributed to the high demand monitoring devices due to rising prevalence of diabetes.
Based on modality the market is segmented into wearable, non wearable/benchtop & embedded devices. Out of which wearable is expected to hold a dominant position in the global non-invasive blood glucose monitoring devices market during the forecast period, and this is attributed to the increasing product launch and development by key players in the market
Based on the End User, the market is segmented into hospital, Cinics & homecare settings. Out of which, the hospital segment is expected to hold a dominant position in the global non-invasive blood glucose monitoring devices market during the forecast period, and this is attributed to the increasing number of hospitals due to increasing healthcare expenditure by countries
Browse 35 Market Data Tables and 39 Figures spread through 180 Pages and in-depth TOC on Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology (EM Waves, Transdermal, Optical, Enzymatic), Modality (Wearable, Non-wearable/Benchtop, Embedded Devices) By End User (Hospitals, Clinics, Homecare setting), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
Key Developments:
- In January 2020, Samsung Advanced Institute of Technology (SAIT), Korea based electronic device company research center, announced collaboration with Massachusetts Institute of Technology (MIT), developed an innovative, non-invasive method for monitoring blood glucose levels that utilizes a technique known as Raman spectroscopy.
- In October, 2023, Phillips-Medisize, a global digital technology company involved in manufacturing of pharmaceutical drug delivery, invitro diagnostic and medtech devices, announced collaboration with GlucoModicum, an innovative medtech company based in Finland, proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM).
- In September 2021, Know Labs, Inc., U.S. based non-invasive health monitoring devices developing companies, announced a new portable medical-grade glucose monitoring device that utilizes Bio-RFID, announced the expansion of Non-invasive glucose monitoring product portfolio,
Key Takeaways of the Global Non-Invasive Blood Glucose Monitoring Devices Market:
- The global Non-Invasive Blood Glucose Monitoring Devices Market is expected to exhibit a CAGR of 15.7% during the forecast period.
- Among region, North America is expected to be the dominant region in the global Non-Invasive Blood Glucose Monitoring Devices Market due to increasing investments by key market players.
- Major players operating in the global Non-Invasive Blood Glucose Monitoring Devices Market include Baxter International Inc., Dexcom, Inc, Abbott Laboratories, Medtronic Plc, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
